A Study to Evaluate the Pharmacokinetics,Safety and Tolerability of Y-2 Sublingual Tablet in Healthy Adult Subjects
Clinical trial NCT05940883 · COMPLETED
Trial details
- NCT number
- NCT05940883
- Sponsor
- Simcere Pharmaceutical Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-06
- Primary completion
- 2023-11-21
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.